Avaliação hormonal e de marcadores séricos em pacientes com abortamento Hormonal and serum marker evaluation in patients with abortion

Avaliação hormonal e de marcadores séricos em pacientes com abortamento Hormonal and serum marker evaluation in patients with abortion

Estudos têm demonstrado a utilização de glicoproteínas e hormônios para prognosticar a evolução de uma gravidez complicada por ameaça de abortamento. Entretanto, alguns resultados ainda são duvidosos. Portanto, o objetivo deste estudo foi avaliar as dosagens de CA-125, CA-19.9, CA-15.3, beta-hCG, es...

Full description

Bibliographic Details
Main Authors:	Eddie Fernando Candido Murta, Renata Almeida Pires Marcelo Balabem Carloni, Elizabete Lilian Dair
Format:	Article
Language:	English
Published:	Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 1998-03-01
Series:	Revista Brasileira de Ginecologia e Obstetrícia
Subjects:	Aborto Marcadores CA-125 CA-15.3 CA-19.9 alfa-Fetoproteína Antígeno cárcino-embrionário Estradiol Gonadotrofina Progesterona Abortion a-Fetoprotein CEA Progesterone
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72031998000200006

Similar Items

Strategies for five tumour markers in the screening and diagnosis of female breast cancer
by: Jun Luo, et al.
Published: (2023-01-01)

Akut apandisitte Ca125, CA19.9 ve karsinoembriyonik antijen gibi tümör belirteçlerinin rolü
by: Sevil Kurban, et al.
Published: (2015-09-01)

Tumor biomarkers CEA, CA19.9, CA15.3 and AFP levels in the serum of patients with COVID-19
by: Abubaker H. Ali, et al.
Published: (2022-04-01)

Exploring The Impact of Capecitabine Treatment on Hormonal and Biochemical Markers in Women with Breast Cancer
by: Raaid Fadhl Abbas Masoudi, et al.
Published: (2023-11-01)

Experience and Lessons Learned in the Treatment of Transforming Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review
by: Binbin Song, et al.
Published: (2024-02-01)

Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
by: Guo Junhong, et al.
Published: (2017-05-01)

Predictive Role of Serum Tumor Markers in Diagnosis of Pulmonary Tuberculosis
by: Jingjing MA, et al.
Published: (2016-04-01)

Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
by: LI Shaolei, et al.
Published: (2018-01-01)

Clinical Value of Platelet and Its Parameters Combined with Tumor Markers in Preoperative Differentiation of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
by: ZHANG Haodong, et al.
Published: (2022-03-01)

Malignant Melanoma Arising in an Ovarian Mature Cystic Teratoma - A Rare Entity
by: RANJINI KUDVA, et al.
Published: (2015-04-01)

Correlation between the Level of the Tumor Markers with the Stage of Liver Fibrosis in Patients with Chronic Hepatitis and Cirrhosis
by: Maryam Heydarpour, et al.
Published: (2011-11-01)

The Value of CA125 and CA19-9 in the Diagnosis of Stage Ⅲ and Ⅳ Endometriosis
by: Wenwen Zhang, et al.
Published: (2024-02-01)

Yüksek Serum CA19-9 Seviyeleri ile Seyreden Bir Endometriozis Olgusu
by: Özlem Nuray Sever, et al.
Published: (2019-03-01)

Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites
by: Fang Liu, et al.
Published: (2014-05-01)

Study of Serum CEA and Ca 19.9 in Esophageal Squamous Carcinoma and ROC Curve Analysis
by: Sawmik Das, et al.
Published: (2020-12-01)

The correlation of tumor markers, neutrophil/lymphocyte ratio and FDG PET/CT measures in pancreatic cancer
by: Reyhan Koroglu, et al.
Published: (2021-07-01)

Simultaneous Assay of CA 72-4, CA 19-9, CEA and CA 125 in Biological Samples Using Needle Three-Dimensional Stochastic Microsensors
by: Alexandru-Adrian Bratei, et al.
Published: (2023-09-01)

A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme
by: Jun Zhu, et al.
Published: (2021-04-01)

Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients
by: Amir Bahrami-Ahmadi, et al.
Published: (2012-01-01)

Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms
by: Lars Schröder, et al.
Published: (2023-09-01)

Biliary Peritonitis due to a Ruptured Amebic Liver Abscess Mimicking a Periampullary Tumor and Liver Metastases with the Elevation of CA 19-9 and CA 125: A Case Report
by: Javiera Marin-Leiva, et al.
Published: (2018-06-01)

Primary Cutaneous Mucinous Carcinoma Monitoring: A Role for CA15.3 and CEA?
by: Antonin Ginguay, et al.
Published: (2022-12-01)

Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis
by: Vivian Ferreira do Amaral, et al.

Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer
by: Jianli Su, et al.
Published: (2022-09-01)

CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity
by: Alpana Singh, et al.
Published: (2019-05-01)

Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man
by: Fumiko Satoh, et al.
Published: (2021-09-01)

Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma
by: Jihyun Keum, et al.
Published: (2023-08-01)

Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts
by: Ömer Ant, et al.
Published: (2015-06-01)

Extremely high serum CA19-9 level along with elevated D-dimer in assisting detection of ruptured ovarian endometriosis
by: Ting Shuang, et al.
Published: (2022-12-01)

Serum CYFRA 21-1 in Egyptian women with breast cancer
by: Samia A. Ebied, et al.
Published: (2017-03-01)

The combination of methylenehydrofolate reductase C677T polymorphism screening and gastrointestinal tumor markers detection may be an early screening method for gastrointestinal cancer related to helicobacter pylori infection
by: Xiaoxing Wu, et al.
Published: (2021-11-01)

Metástasis óseas múltiples de cáncer de mama: Papel del CA 15.3 y respuesta a la hormonoterapia
by: Nayara López C, et al.
Published: (2012-01-01)

Composition and Laboratory Examination Characteristics of 187 Colorectal Cancer Patients with Schistosomiasis
by: YANG Jianghua, et al.
Published: (2019-09-01)

Struma Ovarii with Elevated Ca-125 Levels and Ascites Mimicking Advanced Ca Ovary
by: Navin Kumar Sinha
Published: (2014-03-01)

The possible role of tumor antigen CA 15-3, CEA and ferritin in malignant and benign disease
by: Nafija Serdarević, et al.
Published: (2012-09-01)

Masa Pélvica: características y forma de evaluación en el Instituto Oncológico Nacional.
by: Jaime Sánchez S., et al.
Published: (2022-04-01)

Ovarian fibroma: An unusual morphological presentation with elevated CA-125
by: Arya Anupama, et al.
Published: (2008-10-01)

CA 125: History, Current Status, and Future Prospects
by: Robert C., Jr Bast, et al.
Published: (2020-12-01)

The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence
by: Lina Niu, et al.
Published: (2023-01-01)

Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C
by: Rana R. El Sadda, et al.
Published: (2023-02-01)